Member Login - Account - Logout

Science and Technology Australia
  • Home
  • About STA
    • About Us
    • Executive and governance
    • Reconciliation Action Plan
    • Policy Vision
    • Policy Wins
    • Work for us
  • News and Publications
    • Latest news
    • Submissions, reports and publications
    • 2025 STA Federal Election Priorities
  • Our Programs
    • Science Meets Parliament
    • Superstars of STEM
    • Super STEM workshops
    • STEM Ambassadors
    • Parliamentary Friends of Science
    • Science Policy Fellows Alumni
  • STA Membership
    • STA Membership
    • Our Members
    • Member How-to Guides
    • Login to member portal
    • Register for member portal
  • Contact
  • Home
  • About STA
    • About Us
    • Executive and governance
    • Reconciliation Action Plan
    • Policy Vision
    • Policy Wins
    • Work for us
  • News and Publications
    • Latest news
    • Submissions, reports and publications
    • 2025 STA Federal Election Priorities
  • Our Programs
    • Science Meets Parliament
    • Superstars of STEM
    • Super STEM workshops
    • STEM Ambassadors
    • Parliamentary Friends of Science
    • Science Policy Fellows Alumni
  • STA Membership
    • STA Membership
    • Our Members
    • Member How-to Guides
    • Login to member portal
    • Register for member portal
  • Contact
4 March 2019

Strong and bold investment in critical Cardiovascular research

Minister for Health, Greg Hunt and Gemma Figtree from ACvA

$220 million of new funding from the Medical Research Future Fund (MRFF) has been invested in crucial Australian Cardiovascular research.

The announcement supports a Mission for Cardiovascular Health that has been developed by the Australian Cardiovascular Alliance (ACvA), which brings together the country’s major scientific societies in the field, including institutions, RACGP, industry and partners with the Heart Foundation for the advancement of heart, stroke and vascular disease research.

The ACvA, a member of Science & Technology Australia (STA), said one in three Australians currently die from heart disease and cardiovascular disease costs the community $8.8 billion a year. It is the country’s largest direct health cost.

While the identification and treatment of modifiable risk factors for cardiovascular disease, such as smoking, high cholesterol, high blood pressure, etc, have led to a substantial reduction in cardiac illness and death in Australia, an increasing proportion of patients with heart problems don’t have these risk factors.

STA CEO, Kylie Walker, commended the strategic investment.

“Cardiovascular research will directly and indirectly impact the lives of all Australians,” she said.

“Advances in cardiovascular disease diagnosis and treatment demonstrate the power of long-term, strategic investment in research – this new investment will significantly enhance Australia’s capacity to advance and apply knowledge in this crucial sphere. STA urges a similarly strategic approach to public investment across all scientific and technological disciplines.”

More information on the announcement can be found on the ACvA website.

Share
cardiovascular medical technology
Previous StorySexual harassment a significant issue for STEM sector
Next StoryInternational Womens Day: It’s time to #NominateHer

Related Articles

  • mark.hutchinson2
    Media Release: STA announces new President-elect and Executive
  • 190509_SSofSTEM_W2_012A2062
    DIVERSITY GAINS IN AUSTRALIA'S STEM WORKFORCE - BUT MORE NEEDED

ABOUT US

Science & Technology Australia (STA) is Australia’s peak body in science and technology. We represent more than 235,000 scientists, engineers and technologists. STA is an influential voice for evidence and expertise in public policy.

Recent news

  • Honouring Indigenous Knowledge, Leadership, and Connection This NAIDOC Week
  • Research and innovation will lift Australia out of the productivity doldrums
  • Congratulations to STA President Sharath Sriram – new Chief Scientist of Western Australia

Our members

  • All Members
  • Agricultural and Food Sciences
  • Aquatic Sciences
  • Biological Sciences
  • Chemical Sciences
  • General Science and Technology
  • Geographical and Geological Sciences
  • Mathematical Sciences
  • Medical and Cognitive Sciences
  • Physical Sciences
  • Plant and Ecological Sciences
  • Technological Sciences

Search for news

Most popular

  • R&D investment a sure bet on the future
  • Congratulations to STA President Sharath Sriram – new Chief Scientist of Western Australia
  • Congratulations Labor – now let’s build an Australia powered by Australian ideas
  • Research and innovation will lift Australia out of the productivity doldrums
  • Honouring Indigenous Knowledge, Leadership, and Connection This NAIDOC Week

Sign up to our newsletter

Science and Technology Australia Limited (STA) (ACN 664 679 056 and ABN 71 626 822 845) is a company limited by guarantee. STA was formerly known as Federation of Australian Scientific and Technological Societies Inc and was authorised under section 82 of the Associations Incorporation Act 1991 (ACT) to transfer its registration under the Corporations Act 2001 (Cth) to its new company structure on 3 January 2023.

STA PRIVACY POLICY

OTHER STA POLICIES

ACNC Registered Charity Logo

Copyright © 2024 Science & Technology Australia. All Rights Reserved